Back
Catalent 10K Form
Sell
22
CTLT
Catalent
Last Price:
59.14
Seasonality Move:
17.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTLT News And Ratings
See the #1 stock for the next 7 days that we like better than CTLT
CTLT Financial Statistics
Sales & Book Value
| Annual Sales: | $4.38B |
|---|---|
| Cash Flow: | $4M |
| Price / Cash Flow: | 108.5 |
| Annual Sales: | $19.52 |
| Price / Book: | 3.03 |
Profitability
| EPS (TTM): | -2.27000 |
|---|---|
| Net Income (TTM): | $-413M |
| Gross Margin: | $953M |
| Return on Equity: | -11.29% |
| Return on Assets: | -4.18% |
Catalent Earnings Forecast
Key Catalent Financial Ratios
- The Gross Profit Margin over the past 14 years for CTLT is 21.75%.
- The Selling, General & Administrative Expenses for CTLT have been equal to 21.34% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -24.35% of Operating Income.
- The Net Earning history of CTLT is -23.81% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 6 years.
Catalent Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CTLT |
| CUSIP: | 148806 |
| Website: | catalent.com |
Debt
| Debt-to-Equity Ratio: | 1.39 |
|---|---|
| Current Ratio: | 2.51 |
| Quick Ratio: | 1.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 33.78 |